Skip to content
DraconiticResearch
Search Sources API
182,469 studies31 sourcesUpdated 39 min ago
Peer-reviewedCC BY-NCJournal of pain research

Quantifying the Health and Productivity Burden of Migraine Among Working-Age Women in Western Europe, 2023-2029: A Global Burden of Disease Study 2023 Analysis.

  • Jiaxuan Peng1,2
  • Liujie Chen1,2,3
  • Haoyang Hu1,2,3
  • Fei Yang1,2,3
  1. 1Department of Neurology, The First Medical Centre, Chinese PLA General Hospital, Beijing, 100853, People's Republic of China.
  2. 2Medical School of Chinese PLA, Beijing, 100853, People's Republic of China.
  3. 3International Headache Centre, Chinese PLA General Hospital, Beijing, People's Republic of China.
Read full textPDFDOICite

Abstract

Background

Migraine is a significant public health issue and a leading cause of disability globally. This study quantified the health and productivity burden of migraine among women aged 20-64 years in Western Europe from 2023 to 2029.Methods

We used a Bayesian productivity-adjusted life-year framework with archived Bayesian age-period-cohort projections. Data were derived from Global Burden of Disease Study 2023 estimates. The analysis included disability-adjusted life years (DALYs), estimated productivity-adjusted life years (PALYs) lost, and productivity-related monetary valuation in 2021 constant international dollars (Int$), discounted to 2023.Results

From 2023 to 2029, the age-specific inputs summed to 10.867 million DALYs and 1.082 million estimated PALYs lost. The cumulative monetary valuation was Int$69.85 billion, and sensitivity estimates ranged from Int$66.07 billion to Int$76.32 billion. In a separate female age-standardized comparison, Belgium had the highest available 2023 country estimate at 1443.61 DALYs per 100,000 women.Conclusion

Migraine represents a substantial health and productivity burden among working-age women in Western Europe. The monetary estimate depends on the archived coefficients and valuation inputs and should not be interpreted as observed GDP loss or treatment-attributable savings.

Related

  1. Smallholder farmers' preferences for public expenditure priorities to support maize productivity: evidence from a best–worst scaling experiment in western Kenya
    Fido Orawo, Dickson Okello, John Olwande
    Frontiers in Sustainable Food SystemsPeer-reviewedCC BYFull textGeneral biologyNutritionDOAJ
  2. The effect of sleep quality and depressive symptoms on the relationship between burnout and health-related productivity loss in nurses working in intensive care: a cross-sectional study from the Chinese nurses' health cohort study (TARGET).
    Xueyan Liu, Juan Kong, Xiaodong Yuan +4
    BMC nursingPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMCDOAJ
  3. Quantifying Fine-scale Vegetation Associated with Ixodes scapularis Density to Inform Public Health Programming, Western Massachusetts
    J. M. Tsalah, V. Bobskill, J. Ravenhurst +4
    medRxivPreprintCC BY-NDFull textEpidemiology & public healthmedRxiv
  4. Migraine burden inequities and 2050 projections in Africa based on global burden of disease 2023
    Guangshuang Lu, Yun Wang, Shaobo Xiao +8
    iSciencePeer-reviewedCC BY-NC 4.0Full textNeurologyCell PressCrossrefEurope PMC
  5. Menopausal status modifies the association between migraine and cardiovascular disease risk: a nationwide cohort study
    Do Yeon Kim, Kyungdo Han, Jeen Hwa Lee +6
    The Journal of Headache and PainPeer-reviewedCC BY-NC-ND 4.0Full textPsychiatry & mental healthPMC

Cite

BibTeXRIS
BibTeX
@article{peng2026quantifying,
  title = {{Quantifying the Health and Productivity Burden of Migraine Among Working-Age Women in Western Europe, 2023-2029: A Global Burden of Disease Study 2023 Analysis.}},
  author = {Jiaxuan Peng and Liujie Chen and Haoyang Hu and Fei Yang},
  journal = {Journal of pain research},
  year = {2026},
  month = oct,
  doi = {10.2147/jpr.s645854},
  url = {https://europepmc.org/article/MED/42968965},
  note = {CC BY-NC},
}
RIS
TY  - JOUR
TI  - Quantifying the Health and Productivity Burden of Migraine Among Working-Age Women in Western Europe, 2023-2029: A Global Burden of Disease Study 2023 Analysis.
AU  - Jiaxuan Peng
AU  - Liujie Chen
AU  - Haoyang Hu
AU  - Fei Yang
PY  - 2026
DA  - 2026/10/28
JO  - Journal of pain research
DO  - 10.2147/jpr.s645854
UR  - https://europepmc.org/article/MED/42968965
AB  - Background  Migraine is a significant public health issue and a leading cause of disability globally. This study quantified the health and productivity burden of migraine among women aged 20-64 years in Western Europe from 2023 to 2029.Methods  We used a Bayesian productivity-adjusted life-year framework with archived Bayesian age-period-cohort projections. Data were derived from Global Burden of Disease Study 2023 estimates. The analysis included disability-adjusted life years (DALYs), estimated productivity-adjusted life years (PALYs) lost, and productivity-related monetary valuation in 2021 constant international dollars (Int$), discounted to 2023.Results  From 2023 to 2029, the age-specific inputs summed to 10.867 million DALYs and 1.082 million estimated PALYs lost. The cumulative monetary valuation was Int$69.85 billion, and sensitivity estimates ranged from Int$66.07 billion to Int$76.32 billion. In a separate female age-standardized comparison, Belgium had the highest available 2023 country estimate at 1443.61 DALYs per 100,000 women.Conclusion  Migraine represents a substantial health and productivity burden among working-age women in Western Europe. The monetary estimate depends on the archived coefficients and valuation inputs and should not be interpreted as observed GDP loss or treatment-attributable savings.
SN  - 1178-7090
ER  -